(Q36318189)

13 August 2017

1 reference

title

Oncolytic adenoviruses - selective retargeting to tumor cells (English)

1 reference

13 August 2017

1 reference

1 reference

3

David T Curiel

1 reference

13 August 2017

J Michael Mathis

1

1 reference

PubMed ID

16299537

13 August 2017

Mariam A Stoff-Khalili

series ordinal

2

1 reference

PubMed ID

16299537

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

24

1 reference

13 August 2017

7775-7791

1 reference

13 August 2017

52

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209044

13 August 2017

0 references

cites work

Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Alphaviruses and their derived vectors as anti-tumor agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Genetically targeted adenovirus vector directed to CD40-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Optical imaging of Renilla luciferase reporter gene expression in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

MTH-68/H oncolytic viral treatment in human high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Structure of adenovirus fibre. I. Analysis of crystals of fibre from adenovirus serotypes 2 and 5 by electron microscopy and X-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Gene therapy for meningioma: improved gene delivery with targeted adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Replication-defective vector based on a chimpanzee adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Cancer gene therapy clinical trials: lessons for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Microtubule-independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

A soluble CAR-SCF fusion protein improves adenoviral vector-mediated gene transfer to c-Kit-positive hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Productive replication of human adenovirus type 5 in canine cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

The adenovirus capsid: major progress in minor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Identification of sites in adenovirus hexon for foreign peptide incorporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Visualizing gene expression by whole-body fluorescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Human adenovirus serotypes 4 and 11 show higher binding affinity and infectivity for endothelial and carcinoma cell lines than serotype 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Blood clearance rates of adenovirus type 5 in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

The 'blue eye' phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Fiber gene and genomic origin of human adenovirus type 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Targeting of adenoviral vectors through a bispecific single-chain antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Sindbis virus--an effective targeted cancer therapeutic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Noninvasive imaging of reporter gene expression in living subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

CAR chasing: canine adenovirus vectors-all bite and no bark?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Fluorescently labeled adenovirus with pIX-EGFP for vector detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

The product of the adenovirus intermediate gene IX is a transcriptional activator.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Comparison of the immunological properties of two canine adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Biophysical comparison of two canine adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Structure of adenovirus fibre. II. Morphology of single fibres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Induction and inhibition of innate inflammatory responses by adenovirus early region proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus type 11 uses CD46 as a cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Development of adenovirus serotype 35 as a gene transfer vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Factors that limit the effectiveness of herpes simplex virus type 1 for treatment of oral cancer in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+ CD38- hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

New developments in the virus therapy of cancer: a historical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Image reconstruction reveals the complex molecular organization of adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Oncolytic adenoviral therapy in gallbladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Systemic tumor targeting and killing by Sindbis viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Recombinant adenovirus vectors with knobless fibers for targeted gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Molecular composition of the adenovirus type 2 virion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

A recombinant E1-deleted porcine adenovirus-3 as an expression vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Why did p53 gene therapy fail in ovarian cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Evaluation of promoters for foreign gene expression in the E3 region of bovine adenovirus type-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209044

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209044

1 reference

13 August 2017

1 reference

PubMed ID

16299537